Dr Aakanksha Dixit
Postdoctoral Research Fellow
UQ Centre for Clinical Research
+61 7 334 66022
Journal Articles
Lalor, Richard, Tanaka, Akane, Shiels, Jenna, Dixit, Aakanksha, Hoadley, Sabine, Dufourd, Eloïse, Hamon, Siobhan, To, Joyce, Taggart, Clifford C., Weldon, Sinead, O'Brien, Bronwyn, Greer, Judith, Dalton, John P. and Donnelly, Sheila (2025). An immunoregulatory amphipathic peptide derived from Fasciola hepatica helminth defense molecule (FhHDM ‐1.C2 ) exhibits potent biotherapeutic activity in a murine model of multiple sclerosis. The FASEB Journal, 39 (4) e70380, e70380. doi: 10.1096/fj.202400793rr
Dixit, Aakanksha, Savage, Hannah S. and Greer, Judith M. (2023). An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models. Expert Opinion on Therapeutic Targets, 27 (7), 553-574. doi: 10.1080/14728222.2023.2236301
Dixit, Aakanksha, Tanaka, Akane, Greer, Judith M and Donnelly, Sheila (2017). Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. International Journal of Molecular Sciences, 18 (10) 2141, 1-17. doi: 10.3390/ijms18102141
Lund, Maria E., Greer, Judith M., Dixit, Aakanksha, Alvarado, Raquel, McCauley-Winter, Padraig, To, Joyce, Tanaka, Akane, Hutchinson, Andrew T., Robinson, Mark W., Simpson, Ann M., O'Brien, Bronwyn A., Dalton, John P. and Donnelly, Sheila (2016). A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Scientific Reports, 6 (1) 37789, 37789. doi: 10.1038/srep37789
Ji, Niannian, Somanaboeina, Animesh, Dixit, Aakanksha, Kawamura, Kazuyuki, Hayward, Neil J., Self, Christopher, Olson, Gary L. and Forsthuber, Thomas G. (2013). Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. Journal of Immunology, 191 (10), 5074-5084. doi: 10.4049/jimmunol.1300407
Cantor, Jason R., Yoo, Tae Hyeon, Dixit, Aakanksha, Iverson, Brent L., Forsthuber, Thomas G. and Georgiou, George (2011). Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proceedings of the National Academy of Sciences of the United States of America, 108 (4), 1272-1277. doi: 10.1073/pnas.1014739108
Conference Papers
Donnelly, Sheila, Greer, Judith and Dixit, Aakanksha (2017). Using a parasite derived peptide to prevent immune-mediated demyelination. Progress in MS Research Conference, Sydney Australia, 11-13 October 2017. London, United Kingdom: Sage Publications.
Dixit, A., Donnelly, S., Lund, M. A., Dalton, J. P. and Greer, J. M. (2016). Protection against development of a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley. doi: 10.1002/eji.201670200
Thesis
Dixit, Aakanksha (2022). Investigating the mechanism of action of a novel therapeutic derived from parasitic worms in animal models of multiple sclerosis. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/4f7dd64